Technology
Health
Medical

IRIDEX

$4.44
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.15 (-3.37%) Today
+$0.14 (3.26%) After Hours

Why Robinhood?

You can buy or sell IRIDEX and other stocks, options, ETFs, and crypto commission-free!

About

IRIDEX Corp. engages in developing, manufacturing, and marketing medical systems, delivery devices and consumable instrumentation for the ophthalmology market. Its products include lasers, laser delivery and glaucoma devices, retinal surgical instruments, veterinary, and ENT. Read More The company was founded by Eduardo Arias, Theodore A. Boutacoff, David M. Buzawa and James L. Donovan in February 1989 and is headquartered in Mountain View, CA.

Employees
116
Headquarters
Mountain View, California
Founded
1989
Market Cap
60.50M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
28.44K
High Today
$4.45
Low Today
$4.22
Open Price
$4.42
Volume
1.70K
52 Week High
$9.48
52 Week Low
$3.72

Collections

Technology
Health
Medical
Manufacturing
Advertising and Marketing
Business Services
US
North America

News

Simply Wall StMar 15

Is IRIDEX Corporation (NASDAQ:IRIX) Overpaying Its CEO?

In 2012 William Moore was appointed CEO of IRIDEX Corporation (NASDAQ:IRIX). This report will, first, examine the CEO compensation levels in comparison to CEO compensation at companies of similar size.

1
Associated PressMar 5

IRIDEX Announces 2018 Fourth Quarter and Full Year Financial Results

This content is a press release from our partner Globe Newswire. The AP newsroom and editorial departments were not involved in its creation. This content is a press release from our partner Globe Newswire. The AP newsroom and editorial departments were not involved in its creation. MOUNTAIN VIEW, Calif., March 05, 2019 (GLOBE NEWSWIRE) -- IRIDEX Corporation (Nasdaq: IRIX) today reported financial results for the fourth quarter and year ended December 29, 2018. Fourth Quarter Highlights -- Cyclo G6® pro...

3
Simply Wall StFeb 26

Such Is Life: How IRIDEX Shareholders Saw Their Shares Drop 53%

Want to participate in a short research study? Help shape the future of investing tools and receive a $20 prize! If you are building a properly diversified stock portfolio, the chances are some of your picks will perform badly. But the long term shareholders of IRIDEX Corporation (NASDAQ:IRIX) have had an unfortunate run in the last three years. So they might be feeling emotional about the 53% share price collapse, in that time. And over the last year the share price fell 23%, so we doubt many shareholders...

2

Earnings

-$0.44
-$0.33
-$0.23
-$0.12
Q2 2017
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Estimated
Actual
Expected May 2, After Hours
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.